Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Head-to-head comparison of paliperidone ER vs olanzapine on metabolic effects in schizophrenia
2006-006967-22Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in schizophrenia comparing Paliperidone ER with Olanzapine (2 arms). Primary endpoint: Change in triglyceride to HDL cholesterol ratio. Started Jun 2007; status: completed.
02
Drugs
paliperidoneolanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2006-006967-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006967-22.